Arteris Stock Alpha and Beta Analysis
| AIP Stock | USD 15.50 0.11 0.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Arteris. It also helps investors analyze the systematic and unsystematic risks associated with investing in Arteris over a specified time horizon. Remember, high Arteris' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Arteris' market risk premium analysis include:
Beta 3.39 | Alpha 0.7 | Risk 6.35 | Sharpe Ratio 0.11 | Expected Return 0.71 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Arteris Backtesting, Arteris Valuation, Arteris Correlation, Arteris Hype Analysis, Arteris Volatility, Arteris History and analyze Arteris Performance. Arteris Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Arteris market risk premium is the additional return an investor will receive from holding Arteris long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arteris. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Arteris' performance over market.| α | 0.70 | β | 3.39 |
Arteris expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Arteris' Buy-and-hold return. Our buy-and-hold chart shows how Arteris performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Arteris Market Price Analysis
Market price analysis indicators help investors to evaluate how Arteris stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arteris shares will generate the highest return on investment. By understating and applying Arteris stock market price indicators, traders can identify Arteris position entry and exit signals to maximize returns.
Arteris Return and Market Media
The median price of Arteris for the period between Thu, Oct 2, 2025 and Wed, Dec 31, 2025 is 13.83 with a coefficient of variation of 14.46. The daily time series for the period is distributed with a sample standard deviation of 2.06, arithmetic mean of 14.27, and mean deviation of 1.55. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 50000 shares by Bayview Legacy, Llc of Arteris at 13.0742 subject to Rule 16b-3 | 10/08/2025 |
2 | Why Arteris Inc. stock could benefit from AI revolution - Bond Market Fast Entry Momentum Trade Alerts - newser.com | 10/29/2025 |
3 | Disposition of 32775 shares by Laurent Moll of Arteris at 15.4233 subject to Rule 16b-3 | 11/12/2025 |
4 | Arteris, Inc. AIP Shares Acquired by Acadian Asset Management LLC - MarketBeat | 11/13/2025 |
5 | Disposition of 17264 shares by Laurent Moll of Arteris at 8.9417 subject to Rule 16b-3 | 11/21/2025 |
6 | Disposition of 5000 shares by Paul Alpern of Arteris at 14.2989 subject to Rule 16b-3 | 12/01/2025 |
7 | Arteris Selected by Black Sesame Technologies for Next Generation of Intelligent Driving Silicon | 12/02/2025 |
8 | Disposition of 202 shares by Laurent Moll of Arteris at 14.79 subject to Rule 16b-3 | 12/03/2025 |
9 | Disposition of 60000 shares by Janac K Charles of Arteris at 17.0779 subject to Rule 16b-3 | 12/05/2025 |
10 | Disposition of 70000 shares by Janac K Charles of Arteris at 17.7138 subject to Rule 16b-3 | 12/08/2025 |
11 | Insider Selling Arteris COO Sells 17,937 Shares of Stock | 12/10/2025 |
12 | AIP Publishing Appoints Yi Cao as Editor-in-Chief of Biophysics Reviews | 12/11/2025 |
13 | 12 Information Technology Stocks Moving In Fridays Intraday Session | 12/12/2025 |
14 | AIP Publishing and ACA The Structural Science Society Appoint Mark Wilson Editor-in-Chief of Structural Dynamics | 12/16/2025 |
15 | Will Arteris Inc. stock deliver shareholder value - July 2025 Gainers Long-Term Capital Growth Strategies - DonanmHaber | 12/19/2025 |
16 | Brokerages Set Arteris, Inc. Target Price at 17.50 | 12/26/2025 |
About Arteris Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Arteris or other stocks. Alpha measures the amount that position in Arteris has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.11 | 0.22 | 0.16 | 0.19 | Revenue Per Share | 1.55 | 1.5 | 1.48 | 1.14 |
Arteris Upcoming Company Events
As portrayed in its financial statements, the presentation of Arteris' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arteris' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Arteris' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Arteris. Please utilize our Beneish M Score to check the likelihood of Arteris' management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Arteris
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Arteris Stock Analysis
When running Arteris' price analysis, check to measure Arteris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arteris is operating at the current time. Most of Arteris' value examination focuses on studying past and present price action to predict the probability of Arteris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arteris' price. Additionally, you may evaluate how the addition of Arteris to your portfolios can decrease your overall portfolio volatility.